Emil Kuriakose - 05 Nov 2021 Form 3 Insider Report for Calithera Biosciences, Inc.

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Emil Kuriakose, Name: Emil Kuriakose
Issuer symbol
CALA on OTC
Transactions as of
05 Nov 2021
Net transactions value
$0
Form type
3
Filing time
09 Nov 2021, 18:25:09 UTC
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CALA Common Stock 60,467 05 Nov 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CALA STOCK OPTION (RIGHT TO BUY) 05 Nov 2021 COMMON STOCK 38,000 $15.75 Direct F4
holding CALA STOCK OPTION (RIGHT TO BUY) 05 Nov 2021 COMMON STOCK 12,667 $5.61 Direct F5
holding CALA STOCK OPTION (RIGHT TO BUY) 05 Nov 2021 COMMON STOCK 21,000 $4.64 Direct F6
holding CALA STOCK OPTION (RIGHT TO BUY) 05 Nov 2021 COMMON STOCK 40,000 $7.41 Direct F7
holding CALA STOCK OPTION (RIGHT TO BUY) 05 Nov 2021 COMMON STOCK 33,375 $2.98 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 14,089 shares acquired at various dates pursuant to the Company's 2014 Employee Stock Purchase Plan.
F2 Includes 26,961 shares acquired upon the vesting of a restricted stock unit award, net of shares sold to satisfy tax obligations, arising out of the vesting of previously granted restricted stock units.
F3 Includes an aggregate of 19,417 shares of common stock to be acquired upon the vesting of Restricted Stock Unit awards granted to the Reporting Person. The Restricted Stock Units shall vest as follows: a) 7,417 restricted stock units shall vest according to the following schedule: one-fourth (1/4th) of the shares subject to the Restricted Stock Unit award will vest each year after January 20, 2021 until the Restricted Stock Units are fully vested, b) 12,000 restricted stock units shall fully vest on January 3, 2022. The Restricted Stock Units shall be subject to accelerated vesting as set forth in the Reporting Person's employment agreement with the Company.
F4 One-fourth (1/4th) of the Option vests one year after September 29, 2017; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the Reporting Person's employment agreement with the Company.
F5 One-fourth (1/4th) of the Option vests one year after October 9, 2018; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the Reporting Person's employment agreement with the Company.
F6 One-fourth (1/4th) of the Option vests one year after January 10, 2019; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the Reporting Person's employment agreement with the Company.
F7 One-fourth (1/4th) of the Option vests one year after January 17, 2020; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the Reporting Person's employment agreement with the Company.
F8 One-fourth (1/4th) of the Option vests one year after January 20, 2021; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the Reporting Person's employment agreement with the Company.